P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 14 December 2018 | 9:38 pm

Lilly to Acquire Pre-Clinical Pain Program from Hydra Biosciences

INDIANAPOLIS, Dec. 14, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement with Hydra Biosciences to acquire all assets related to Hydra's more ...

Published 14 December 2018 | 7:09 pm

ABBOTT HIKES ITS DIVIDEND PAYOUT 14%

Our success is your success. We've been rewarding investors since 1924. more ...

Published 14 December 2018 | 6:20 pm

Pfizer Declares First-Quarter 2019 Dividend

Board of Directors approves increase in quarterly cash dividend to $0.36 per share and authorizes new $10 billion share repurchase program more ...

Published 14 December 2018 | 4:34 pm

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEVTM (bevacizumab)

ZIRABEV TM (bevacizumab), a potential biosimilar to Avastin ®* (bevacizumab), is Pfizer's second therapeutic oncology biosimilar to receive a positive CHMP opinion in Europe in more ...

Published 14 December 2018 | 3:51 pm

"For me to live with multiple sclerosis independently is everything... I believe dancing is like a medicine for me."

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in more ...

Published 14 December 2018 | 2:15 pm

Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older

Pfizer Inc. (NYSE:PFE) announced today the initiation of a Phase 3 program for its 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, for the more ...

Published 14 December 2018 | 1:17 pm

Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors

Lilly will leverage Evidation's Andromeda data platform to analyze large scale data aimed at uncovering novel digital measures of health more ...

Published 14 December 2018 | 12:48 pm

Press Release Archives

Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors Lilly will leverage Evidation's Andromeda data platform to analyze more ...

Published 13 December 2018 | 12:45 pm

FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)

INDIANAPOLIS, Dec. 13, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug more ...

Published 13 December 2018 | 12:34 pm

Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease

RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 13, 2018 /PRNewswire/ -- The Duke Clinical Research Institute (DCRI) is leading a new clinical study to optimize care for people more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Vienna, September 25 – 28, 2018

Next Annual General Meeting, Vienna, September 25 – 28, 2018